A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura - Related Studies

A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura

This study has been completed.

Study NCT00002250. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Infection
		Purpura
		Purpura, Thrombocytopenic

3	More general conditions related to this trial
		Blood Coagulation Disorders
		Blood Platelet Disorders
		Hematologic Diseases
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Signs and Symptoms
		Skin Manifestations
		Slow Virus Diseases
		Thrombocytopenia
		Virus Diseases

4	Interventions listed in this trial
		CD4-IgG

5	Additional drug interventions recognized in this trial
		Immunoglobulin G
		Immunoglobulins

6	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Genentech